Notch Signaling
- Department of Developmental Biology, and Department of Medicine (Division of Dermatology), Washington University, St. Louis, Missouri 63110
- Correspondence: kopan{at}wustl.edu
The Notch pathway regulates cell proliferation, cell fate, differentiation, and cell death in all metazoans. Notch itself is a cell-surface receptor that transduces short-range signals by interacting with transmembrane ligands such as Delta (termed Delta-like in humans) and Serrate (termed Jagged in humans) on neighboring cells (Fig. 1). Some soluble ligands have also been identified in Caenorhabditis elegans, but these bind to Notch together with transmembrane adaptors (Komatsu et al. 2008). Ligand binding leads to cleavage and release of the Notch intracellular domain (NICD), which then travels to the nucleus to regulate transcriptional complexes containing the DNA-binding protein CBF1/RBPjk/Su(H)/Lag1 (CSL).
Notch signaling (simplified view).
Following their synthesis, Notch receptors are cleaved by protein convertases during exocytosis at site 1 (S1), which regulates their trafficking and signaling activity (Logeat et al. 1998; Gordon et al. 2009). During passage through the Golgi, they can be glycosylated by glycosyltransferases such as Fringe, which determines the subsequent response to different subfamilies of ligands. These and other posttranslational modifications of the receptors and ligands tune the amplitude and timing of Notch activity to generate context-specific signals. Several proteins, including E3 ubiquitin ligases (e.g., Deltex and Nedd4), Numb, and α-adaptin, regulate the steady-state levels of the Notch receptor at the cell surface. In signal-sending cells, E3 ubiquitin ligases (Neur and MIB) similarly ubiquitylate the intracellular domain of the ligand to promote epsin-mediated endocytosis, which is associated with ligand activation (Fig. 2).
Notch signaling.
Following ligand binding, signaling is initiated when endocytosis of ligand–receptor complexes induces unfolding of a juxtamembrane negative control region (NRR) unique to Notch proteins. Unfolding of the NRR allows access by the protease ADAM10 (also known as KUZ), which removes the Notch extracellular domain by cleaving at site 2 (S2); γ-secretase then cleaves Notch within its transmembrane domain at site 3 (S3) to release various forms of the NICD. Those that have valine or methionine residues at the amino terminus escape the N-end-rule degradation pathway (Tagami et al. 2008) and are stable enough to impact transcription (see below). Interestingly, productive interactions between Notch and its ligands occur when these are present on neighboring cells (i.e., in trans); when receptor and ligand are present on the same cell (i.e., interactions are in cis), activation is inhibited. cis interactions thus determine whether a cell will signal (the ligand is more abundant than Notch) or receive (Notch is more abundant than the ligand) (Sprinzak et al. 2010). Alternatively, in some cases ligand and receptors can be segregated into different subdomains to allow simultaneous transmission and reception of signals (Luty et al. 2007).
Only one nuclear protein is known to mediate the bulk of Notch signals: CSL (Kopan and Ilagan 2009). CSL is a DNA-binding adaptor that interacts with many proteins to build either repressor complexes, which include histone deacetylases (HDACs) that preserve a closed chromatin conformation, or activating complexes, which contain NICD, along with other proteins including histone acetyltransferases (HATs) that open up chromatin. In canonical, CSL-mediated Notch signaling, NICD translocates to the nucleus, binds to CSL, and helps recruit the adaptor protein Mastermind-like (MAML) (Kopan and Ilagan 2009). MAML recruits the HAT p300 and components of the transcription machinery. Thus, every cleaved Notch molecule generates one signaling unit, and tuning the effectiveness of receptor–ligand interaction directly determines the amount of NICD in the nucleus. During the transcriptional activation process, NICD is phosphorylated on a degron within its PEST domain by kinases such as cyclin-dependent kinase 8 (CDK8) and targeted for proteasome-mediated degradation by E3 ubiquitin ligases such as Sel10 (also known as Fbw7). This limits the half-life of a canonical Notch signal and resets the cell for the next pulse of signaling.
In addition to the canonical signals, mounting evidence indicates that CSL-independent activities of Notch also regulate vertebrate (Rangarajan et al. 2001; Demehri et al. 2008) and invertebrate (Ramain et al. 2001) development, but the biochemical details of this aspect of the pathway are yet to be uncovered. In the absence of ligand, Notch may also be involved in other cellular processes, such as regulating the stability of β-catenin (Sanders et al. 2009), a component of the Wnt signaling pathway (Nusse 2012).
Under most physiological conditions, unbound Notch receptors simply recycle or are targeted for lysosomal degradation. With one exception (Mukherjee et al. 2011), only pathological or experimental conditions are known to lead to receptor activation without ligand. These include mutations in the NRR domain (Weng et al. 2004), overexpression of Notch with ADAM proteases, and exposure to calcium chelators (Bozkulak and Weinmaster 2009; van Tetering et al. 2009), all of which expose Notch to shedding by ADAM17 (also known as TACE). Notch can also become activated when ESCRT components are mutated (Moberg et al. 2005; Thompson et al. 2005; Vaccari and Bilder 2005), which delays entry into the lysosome and permits ligand-independent activation. The frequent activation of Notch by mutations in T-cell acute lymphoblastic leukemia and its frequent inactivation in head and neck squamous cell carcinomas (Agrawal et al. 2011; Stransky et al. 2011) illustrate the importance of the pathway for control of cell fate and proliferation and the severe consequences of its dysregulation.
Acknowledgments
Figures adapted with kind permission of Cell Signaling Technology (http://www.cellsignal.com).
Footnotes
-
Editors: Lewis Cantley, Tony Hunter, Richard Sever, and Jeremy Thorner
-
Additional Perspectives on Signal Transduction available at www.cshperspectives.org
- Copyright © 2012 Cold Spring Harbor Laboratory Press; all rights reserved
REFERENCES
*Reference is also in this collection.
